Tetragon Financial Group Limited – Tetragon Financial Group Limited Announcement of Final Results of Tender Offer to Purchase Tetragon Non-Voting Shares

Tetragon Financial Group Limited Announcement of Final Results of Tender Offer
to Purchase Tetragon Non-Voting Shares

LONDON, April 14, 2026 — Tetragon announces the final results of the «modified
Dutch auction» tender offer to purchase a portion of the outstanding non-voting
shares of Tetragon for a maximum aggregate payment of $50,000,000 in cash.  The
tender offer expired at 11:59 p.m. (ET) on 13 April 2026.

J.P. Morgan Securities plc (which conducts its UK investment banking business as
J.P. Morgan Cazenove) acted as dealer manager for the tender offer and
Computershare Investor Services PLC acted as tender agent for the tender offer.
As dealer manager, J.P. Morgan determined the final purchase price at which
Tetragon will purchase shares in the tender offer. As tender agent,
Computershare determined the final proration factor.

In accordance with the terms of the tender offer, Tetragon has accepted for
purchase 3,773,581 non-voting shares at a purchase price of $13.25 per share.
The aggregate cost of this purchase is $49,999,948.25, excluding fees and
expenses relating to the tender offer.  A total of 5,660,906 Tetragon non-voting
shares were properly tendered and not properly withdrawn at or below the
purchase price of $13.25 per share.  Because more than $50,000,000 in value of
Tetragon non-voting shares was properly tendered and not properly withdrawn, the
tender offer was subject to proration pursuant to the terms of the tender offer,
with appropriate adjustments to avoid purchases of fractional shares.  The final
proration factor, which is applicable only to shares properly tendered and not
properly withdrawn at the purchase price of $13.25 per share, is 66.66%, rounded
to the second decimal place. [1]

Tetragon will promptly make payment for the shares validly tendered and accepted
for purchase, which is expected to occur on or about 17 April 2026.  All shares
tendered and not purchased in the tender offer will be promptly returned to the
tendering shareholders.

About Tetragon:

Tetragon Financial Group is a Guernsey closed-ended investment company. Its non
-voting shares are listed on Euronext in Amsterdam, a regulated market of
Euronext Amsterdam N.V., and also traded on the Specialist Fund Segment of the
Main Market of the London Stock Exchange. Our investment manager is Tetragon
Financial Management LP. Find out more
at www.tetragoninv.com/shareholders (https://edge.prnewswire.com/c/link/?t=0&l=en
&o=4664043
-1&h=1990674768&u=https%3A%2F%2Fwww.tetragoninv.com%2Fshareholders&a=www.tetragon
inv.com%2Fshareholders).

Tetragon’s non-voting shares are subject to restrictions on ownership by U.S.
persons and are not intended for European retail investors. Please
see: www.tetragoninv.com/shareholders/additional
-info/ (https://edge.prnewswire.com/c/link/?t=0&l=en&o=4664043
-1&h=3372925867&u=https%3A%2F%2Fwww.tetragoninv.com%2Fshareholders%2Fadditional
-info%2F&a=www.tetragoninv.com%2Fshareholders%2Fadditional-info%2F).

Tetragon Investor Relations:
Yuko Thomas
[email protected]

Press Inquiries:
Prosek Partners
[email protected]
U.K. +44 20 3890 9193
U.S. +1 212 279 3115

This release contains inside information within the meaning of Article 7(1) of
the EU Market Abuse Regulation (2014/596/EU), or EU MAR, and of assimilated EU
MAR as it forms part of the law of the United Kingdom by virtue of the European
Union (Withdrawal) Act 2018 (as amended).

This release does not contain or constitute an offer to sell or a solicitation
of an offer to purchase securities in the United States or any other
jurisdiction. The securities of Tetragon have not been and will not be
registered under the U.S. Securities Act of 1933, as amended, and may not be
offered or sold in the United States or to U.S. persons unless they are
registered under applicable law or exempt from registration. Tetragon does not
intend to register any portion of its securities in the United States or to
conduct a public offer of securities in the United States. In addition, Tetragon
has not been and will not be registered under the U.S. Investment Company Act of
1940, as amended, and investors will not be entitled to the benefits of such
Act. Tetragon is registered in the public register of the Netherlands Authority
for the Financial Markets (Autoriteit Financiële Markten) under Section 1:107 of
the Dutch Financial Markets Supervision Act as an alternative investment fund
from a designated state.

J.P. Morgan Securities plc, which is authorised by the UK Prudential Regulation
Authority and regulated by the UK Financial Conduct Authority and the Prudential
Regulation Authority in the United Kingdom, is acting exclusively for Tetragon
and for no one else in connection with the tender offer and will not be
responsible to anyone (whether or not recipient of the tender offer) other than
Tetragon for providing the protections afforded to the clients of J.P. Morgan
Securities plc or for providing advice in relation to the tender offer.

[]
[1] The full final proration factor applied is 66.6604250273719%.

This information was brought to you by Cision http://news.cision.com